A detailed history of Virtu Financial LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Virtu Financial LLC holds 172,665 shares of SGMO stock, worth $431,662. This represents 0.01% of its overall portfolio holdings.

Number of Shares
172,665
Holding current value
$431,662
% of portfolio
0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$0.32 - $1.1 $55,252 - $189,931
172,665 New
172,665 $150,000
Q2 2023

Jul 27, 2023

BUY
$1.11 - $1.74 $19,163 - $30,039
17,264 New
17,264 $22,000
Q4 2022

Feb 15, 2023

BUY
$2.77 - $5.07 $68,917 - $126,141
24,880 New
24,880 $78,000
Q1 2022

May 17, 2022

SELL
$5.23 - $7.82 $79,370 - $118,676
-15,176 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$7.29 - $10.97 $110,633 - $166,480
15,176 New
15,176 $114,000
Q1 2021

May 19, 2021

SELL
$10.88 - $17.05 $147,347 - $230,908
-13,543 Closed
0 $0
Q4 2020

Feb 24, 2021

SELL
$9.23 - $18.18 $70,969 - $139,786
-7,689 Reduced 36.21%
13,543 $211,000
Q3 2020

Dec 11, 2020

SELL
$9.38 - $12.48 $264,459 - $351,861
-28,194 Reduced 57.04%
21,232 $201,000
Q2 2020

Aug 07, 2020

BUY
$6.21 - $11.83 $229,012 - $436,266
36,878 Added 293.9%
49,426 $443,000
Q4 2019

Feb 04, 2020

SELL
$8.03 - $11.7 $355,022 - $517,280
-44,212 Reduced 77.89%
12,548 $105,000
Q3 2019

Nov 20, 2019

BUY
$9.05 - $12.22 $513,678 - $693,607
56,760 New
56,760 $514,000
Q2 2019

Aug 13, 2019

SELL
$8.75 - $13.03 $222,512 - $331,352
-25,430 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$7.72 - $12.81 $109,739 - $182,094
14,215 Added 126.75%
25,430 $243,000
Q4 2018

Jan 16, 2019

BUY
$9.51 - $16.6 $106,654 - $186,169
11,215 New
11,215 $129,000
Q2 2018

Jul 30, 2018

SELL
$13.9 - $19.8 $231,601 - $329,907
-16,662 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$13.9 - $19.8 $300,545 - $428,115
-21,622 Reduced 56.48%
16,662 $237,000
Q1 2018

May 14, 2018

BUY
$16.7 - $26.35 $639,342 - $1.01 Million
38,284 New
38,284 $727,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $391M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.